Maverick Capital Ltd. Has $104.71 Million Stock Position in Astera Labs, Inc. $ALAB

Maverick Capital Ltd. reduced its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 2.1% during the 1st quarter, Holdings Channel reports. The fund owned 955,356 shares of the company’s stock after selling 20,603 shares during the period. Maverick Capital Ltd.’s holdings in Astera Labs were worth $104,707,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of ALAB. Royal Bank of Canada boosted its holdings in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the period. AQR Capital Management LLC increased its stake in shares of Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC increased its stake in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the period. First Trust Advisors LP lifted its holdings in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. lifted its holdings in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after purchasing an additional 1,977 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ALAB. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Evercore reissued an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. TD Cowen upped their price target on shares of Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research note on Monday, July 13th. Finally, Stifel Nicolaus raised their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $282.52 on Tuesday. The business’s 50 day simple moving average is $360.28 and its 200 day simple moving average is $226.92. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The company has a market capitalization of $48.43 billion, a P/E ratio of 190.89, a P/E/G ratio of 3.38 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Bethany Mayer sold 686 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. This trade represents a 11.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the completion of the transaction, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. The trade was a 5.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock valued at $444,928,806 over the last three months. 10.40% of the stock is owned by insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.